Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Pre-order your Brochure

Our 2016 Speaker Faculty:

Geoff McDonald

Geoff McDonald

VP & General Manager, GSK Australia

Read more

Geoff McDonald is VP and General Manager for GSK Australia. In this role, Geoff managed a significant transformation strategy, positioning the business for the future and leading to successful launches for a number of new medicines and vaccines. These launches have offered Australian patients expanded treatment options in respiratory, oncology and childhood immunisation.

Previously, Geoff was General Manager for GSK New Zealand. During this time Geoff served as a Director on the Medicines NZ Industry Board and as Chairman of VIANZ (Vaccines Industry Alliance Group of NZ), leading industry representation on a broad range of pharmaceutical policy and access issues.

Geoff began his career working in sales and marketing before his appointment as Sales Director for GSK Australia in 2002. He then progressed into regional roles that significantly shaped his career including as Marketing Director for GSK China (2004-07) and Commercial Head Oncology for Asia Pacific in Singapore (2007-09).

Geoff is a strong advocate for improving access to medicines and vaccines in Australia. Through his role as a Director on the Medicines Australia Board, Geoff has engaged with a range of stakeholders on ways to improve regulatory, reimbursement and other access policy settings. Geoff has also played a leadership role in expanding industry transparency including through the introduction of new disclosure and reporting commitments in the 18th Edition of the Medicines Australia Code of Conduct.

Geoff is a member of the Medicines Australia Board, he is an active member of AICD and the CEO Forum and has a special interest in innovation, digital technology and healthcare.

Brian Gladsden

Brian Gladsden

Managing Director and Country President, Novartis Pharmaceuticals Australia and New Zealand

Read more

Brian Gladsden has been Managing Director and Country President of Novartis Australia and New Zealand since July 2015 and also holds a position on the Medicines Australia Board.

Prior to these roles, Brian served as Country President and Head of Pharmaceuticals in Korea.

Brian started his pharmaceutical career with MSD and Bayer, taking on roles of increasing responsibility in Sales, Marketing and Project Management in Italy, Germany, Austria and the US. He joined Novartis in 2001 as Global Brand Manager for Femara and then led the extended and early adjuvant launches as Global Brand Leader. Following his Global experience, he moved to Japan as Head, Early Commercial Development and Marketing Science for Novartis Oncology and then led the Novartis Oncology organisation in Austria and Slovakia as General manager followed by the role of General Manager Novartis Oncology for Australia and New Zealand.

Brian holds a Bachelor of Science degree in Finance and International Business from Pennsylvania State University and a Master of International Business Studies degree from University of South Carolina. He is married and has two children and currently resides in Sydney, Australia.

Albert Spanos

Albert Spanos

General Manager, Celgene

Read more

More information coming soon...

Matt Slabbert

Matt Slabbert

Head of Market Access ANZ, Bayer Australia

Read more

Matt is a multidisciplinary market access professional, he has been academically trained as a pharmacologist as well as a biostatistician and has been awarded Masters Degrees from both the University of Auckland (2008) and the University of Sydney (2014). He applies these fundamental disciplines in the value substantiation of innovative pharmaceuticals both within the health technology assessment (HTA) framework and beyond it.

He has several years’ experience in industry and has been with Bayer Australia Ltd during a prolific period with significant experience in the value negotiation of novel innovative pharmaceutical therapies in the areas of cardiovascular disease, oncology, ophthalmology and women’s healthcare.

He is currently a member of the Senior Leadership Team for Bayer Pharmaceuticals (Australia & NZ). Bayer is a top-tier pharmaceutical manufacturer and is committed to its mission; ‘Science for a Better Life’.

Simon Eade

Simon Eade

VP, Head Asia Pacific Region, Actelion

Read more

Simon is currently Actelion Pharmaceuticals, Vice President and Head of the Asia Pacific Region. He has been responsible for extending Actelion’s reach and the availability of its key orphan drugs across Asia. Actelion now has its own local organizations in China, Hong Kong, Taiwan, South Korea, Singapore, Malaysia, Australia & New Zealand and Japan. In addition it works with partners in Thailand, Vietnam, The Philippines and most recently Indonesia.

Prior to his move to Asia Pacific in 2013, Simon was responsible for Actelion’s Global Strategic Marketing function, as VP and Head of Global Strategic Marketing and was pivotal in the development and launch of Opsumit® (macitentan), Zavesca® (miglustat) and Veletri® (iv. epospotonol) and the pre-launch work on a host of additional Actelion compounds across multiple disease areas, including the recently launched Uptravi® (selexipag).

He holds a Bachelor’s degree in Biochemistry & Protein Engineering and has spent the last 25 years working in various global and local commercial roles in the pharmaceutical industry. Firstly, for Sandoz then Novartis, Serono and most recently Actelion, where he helped establish the UK and Ireland affiliate back in 2002 . The last 15 years have been focused working in the area of orphan drugs and helping develop awareness for conditions like PAH, driving medical education to improve diagnosis and finding ways to enhance access to novel therapies.

Kate Webb

Kate Webb

Head of Market Access and Government Policy, Takeda Australia

Read more

As a scientist who worked in state hospitals before moving to the pharmaceutical industry, Kate is fully aware of the constraints associated with managing health expenditure within a budget. Doing so is particularly challenging in the era of accelerating innovations in many healthcare technologies, not only medicines. In her current role as Head of Market Access and Government Policy, Kate’s primary responsibility is to achieve reimbursement for the company’s specialty care medicines in less common therapeutic areas. Although working within the current Australian HTA environment has many challenges, Kate endeavours to find solutions. She is a firm advocate that finding optimal solutions involves all the stakeholders, both internal and external, and partnering with her Commercial colleagues to find ways to provide timely access to patients is integral to success.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Colin Albert

Colin Albert

Regional GM Molecular Information and Commercial Head Asia Pacific, Roche Pharmaceuticals

Read more

Colin Albert has over 20 years of experience in the Pharma Sector with over 10 years international business experience across a diverse range of cultures, which included an emerging markets international business leader role based in Switzerland for a year, and a commercial excellence role based in Shanghai for three years. In his current role he is responsible for leading strategy and business effectiveness to maximize the number of patients benefitting from Roche Pharma Products. In this role he works closely with Pharma Development and Partnering bodies to ensure new molecules are made available to APAC patients as early as possible. In October 2016 he established the Roche Pharma – Molecular Information Division in APAC, with the aim of championing “Precision Medicine” through the Foundation Medicine range of products, which is based on the latest next generation sequencing technology coupled to an extensive knowledge base. Prior to this Colin held various sales and marketing roles in Australia for Roche as well as AstraZeneca.

Colin holds a BA in Economics and Politics and a Graduate Diploma in Management; he is also a Graduate of the Australian Institute of Company Directors (GAICD).

Tammy Lindrum

Tammy Lindrum

Head of Sales and Key Account Management, Sanofi

Read more

Tammy has over 30 years’ experience within the Pharmaceutical and Consumer Industry.

She has worked in Senior Marketing, Medical and Sales Management roles for the last 25 years.

Tammy has a background in Nursing and studied marketing at Kuring Gai College.

During her career she has worked across a broad range of products and disease states including Dermatology, Anti-infective, Cardiology, Hypertension, Allergy, S8 Pain Medications, Anticoagulants, Diabetes treatments, Devices, Hospital based medications as well as Infant formula.

Tammy Launched Loceryl, Posicor and was responsible for the pre marketing of Xenical and Tamiflu during her 10 years at Roche products where she worked as Business Unit Manager.

She worked as Medical Director with Nutricia overseeing Prebiotics introduced into the Karicare range of Infant formula.

Tammy worked on acquisitions at both Roche and Aventis and is a great advocate for change management when implemented well. Highlights of Tammy’s careers include her twice nominated for the Telstra Business Woman of the year. Both nominations were submitted by the team of Managers she worked with at that time and were based on what they believed to be model leadership and vision.

Tammy also received recognition for the work she completed with the Royal Australasian college of Dermatologists assisting them secure the World Congress of Dermatology...

She was presented with a plaque by Professor Robin Marks recognizing her as an official Ambassador of the Royal Australasian College of Dermatologists for her efforts in assisting the College with their successful bid to secure the Congress for Australia.

Tammy also spent 2 years on the Australian College of Nursing Advisory Board – In this capacity she provided insights into Registered Nurses working outside of the Hospital system.

Tammy currently works with Sanofi as Head of Sales and Key Account Management for the General Medicine Business Unit. She has been with Sanofi for 9 years.

Frances Hall

Frances Hall

Head of Sales, LEO Pharma

Read more

Frances is a an experienced Executive within the Pharmaceutical and Healthcare Industries with a strong background in Sales Force Effectiveness, Commercial Operations, Sales and Business Development. She is currently the Head of Sales for Australia and New Zealand at LEO Pharma. Frances has been the Head of Global Commercial Operations for APAC at Pfizer and was responsible for the transformation changes to improve efficiencies. She has also held role of the Commercial Director at “Global Medical Solutions” a leading-edge provider of nuclear medicine and diagnostic imaging products and services.

Frances has a wealth of experience in leading Sales Teams and helping them develop and improve performance.

Elisha Whitfield

Elisha Whitfield

Head of Sales & Marketing Brintellix, Lundbeck Australia

Read more

More information coming soon...

Penny Shakespeare

Penny Shakespeare

First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health

Read more

Penny Shakespeare is the First Assistant Secretary of the Pharmaceutical Benefits Division in the Australian Department of Health. She has previously worked in the same Department as First Assistant Secretary, Health Workforce Division, and as head of the Department’s Medical Benefits Branch and Private Health Insurance Branch.

Prior to joining the Department of Health, Penny worked as an industrial relations lawyer in the Department of Employment and Workplace Relations, and in regulatory policy roles, including as head of the ACT Office of Industrial Relations. She was a member of the National Occupational Health and Safety Commission and the Workplace Relations Ministers’ Advisory Council.

Penny has a Bachelor of Laws, a Masters degree in International Law and is admitted as a Barrister and Solicitor.

Saul Resnick

Saul Resnick

CEO Australia & New Zealand, DHL Supply Chain

Read more

Saul has propelled innovative supply chain solutions for the Healthcare industry for many years. In both his current role as Australian Managing Director, and previous role as Vice President of Life Sciences and Healthcare across Asia Pacific, Saul has been instrumental in working with DHL’s Healthcare customers to innovate and improve efficiency across their supply chains.

He is passionate about the supply chain due to its essential part of the economy, sustainability and everyday lives of people around the world. As the leader of a business which has a direct and significant impact on customers, Saul is driven to be a strong ambassador for change, innovation and improvement within the global DHL business.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Kate Bentley

Kate Bentley

Multi-channel Marketing Lead and Marketing Excellence Manager, GSK

Read more

Kate Bentley is the Multi-channel Marketing Lead and Marketing Excellence Manager at GSK, Australia.

Kate’s experience includes working in Marketing, Sales Management and Market Research in Australia and the UK before taking on more senior commercial roles across Europe and Emerging Markets. During this time working internationally, Kate spent 12 months working in Japan as a Respiratory Marketing Director and subsequently in a Global Commercial Director role leading the strategy across Europe, EMAP and Japan for two Respiratory pipeline assets.

Coming back to Australia four years ago, Kate’s energy for delivering on customer needs and developing commercial strategy has been focused on the digital marketing space. Kate has positioned Australia as a Wave 0 market for global digital initiatives and sits on GSK’s Global Multi-Channel Marketing Roadmap network.

Kate holds a Bachelor of Economics and Finance and a Masters of Business Administration. Kate and Paul have recently become parents for the first time to Xavier.

Simon McErlane

Simon McErlane

Regional Medical Diretor Australiasia, Alexion

Read more

More information coming soon...

Barrie Littlefield

Barrie Littlefield

Head of Engagement, Cure Brain Cancer Foundation

Read more

More information coming soon...

Paul Bernard

Paul Bernard

Managing Director, Sudler & Hennessey

Read more

Peter worked for 15 years in a range of positions in the pharmaceutical industry, culminating in a Business Unit Manager role for a division of Wyeth in Australia.  After the Pfizer merger, he left to set up his own digital agency which he grew to a team of 20 before merging it into another agency and leaving to join Sudler & Hennessey in March 2016.  As Managing Director at Sudler, Peter leads the agency’s Strategy team and is thus responsible for helping clients get their customers to do what they want them to. 

Angela Scaffidi

Angela Scaffidi

Managing Partner and Head of Change, SenateSHJ

Read more

Angela is SenateSHJ’s head of change, and she designs, implements and measures change programs for clients in the public and private sector. She is an accredited user of the Four Rooms of Change™. She works with the methodology to help individuals, teams and organisations to understand and own their change experience and to take the steps required to achieve sustainable change.

Prior to establishing Scaffidi Hugh-Jones (now SenateSHJ), she worked at McKinsey & Company and Turnbull Porter Novelli. SenateSHJ now has offices in Melbourne, Sydney, Auckland and Wellington.

She has won a range of state, national and international awards for her work, including two Golden World Awards from the International Public Relations Association. Angela is a skilled facilitator and trainer. She regularly designs and facilitates programs in structured problem solving, communication and change. Angela also lectures in the post-graduate PR program at RMIT University.

Stephan Galt

Stephan Galt

Managing Director, Atlantis Healthcare

Read more

Stephen is the Managing Director of Atlantis Healthcare Australia where he leads the development and delivery of all programs and consulting engagements in the Australian and Asian markets. In this role, Stephen works with public health groups, private insurers, patient advocacy organisations and the pharmaceutical and device industry to better understand the drivers of patient behaviour to create integrated solutions to achieve optimal outcomes for all stakeholder in the healthcare system. Stephen has over 10 years’ experience in the Pharmaceutical and Healthcare domain, with roles and projects spanning Asia Pacific, US and European markets.

Sarah Walmsley

Sarah Walmsley

Director of Strategy, Atlantis Healthcare

Read more

Sarah is Director of Strategy for Atlantis Healthcare, supporting its mission to apply behavioural science principles to support people to better manage their own health and wellbeing. Sarah’s career began in Pharmaceutical sales and healthcare advertising, most recently spending nine years in London where she led large European patient engagement research projects and interventional programs in Atrial Fibrillation, Multiple Sclerosis, Alzheimer’s disease and Oncology. In Australia Sarah leads the strategy and health psychology teams at Atlantis Healthcare, with a focus on consulting projects which identify and quantify challenges to optimal health outcomes, and conducting research projects to inform the design and evaluation of interventional programs.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Nayana Vogel

Nayana Vogel

Co-Founder & Managing Director, Hummingbird Insights

Read more

Nayana is an ethical healthcare market research expert with an in-depth knowledge of the strategic imperatives facing the pharmaceutical industry. This is where her passion lies and where she does her best work. Over the years, she has successfully helped large pharmaceutical companies and specialised biotech players launch their product optimally or regain market share they had lost.

Nayana is a strong believer in providing brand teams with a complete picture of the challenges they need to tackle - from defining the business issue to providing its solution. She doesn't take the term 'actionable insights' lightly - she lives and breathes it - that's how she helps her clients achieve business growth for their brand. It is with that aspiration at heart that she founded HUMMINGBIRD INSIGHT, a joint venture with the multi-channel marketing agency SWORDFISH MEDIA.

Caleb Forbes

Caleb Forbes

Commercial Director, SwordFish Media Pty Ltd.

Read more

Caleb is the commercial director at SWORDFISH MEDIA where he helps pharmaceutical clients take a fresh look at how they engage with their customers. He is committed to helping them reach their strategic objectives by deploying the right multi-channel marketing campaign using today's technology to elicit lasting impact. Caleb has engaged in problem solving and communications solutions across the Australian and global market for over 15 years and has built a strong pharmaceutical business acumen through this diverse experience. Caleb is passionate about understanding the market intricacies his pharmaceutical clients face and connecting the dots to deliver insightful solutions.

Shane Pearse

Shane Pearse

Principal, Pivotal Strategic Insights

Read more

Recognised as an expert in his field, Shane has over 25 years’ experience in market research specialising in the pharma industry and related areas. He remains motivated by the difference that better healthcare products and services can make to patients’ lives. And by the amazing personal stories he hears from patients and HCPs that lead to insights that help build great strategy.

He has alternated in his career between multinational research agencies and start-ups. A previous company he co-founded, LifeScience Partners, was sold to IMS in 2012.  Over the years, Shane has become more interested in strategy, forming Pivotal Strategic Insights this year to help companies deal with the challenges of the healthcare sector from reimbursement and launch though to digitally empowered patients.

Shane is a member of the Australian Market & Social Research Society and is certified by them as a Qualified Practicing Market Researcher (QPMR).

Sue Elderton

Sue Elderton

National Policy Manager, Carers Australia

Read more

Sue Elderton is the National Policy Manager of Carers Australia.

Carers Australia is the national peak body representing family and friend carers of people with a disability, chronic disease, mental health or substance abuse problems or who are frail aged.

Prior to working for Carers Australia, Sue worked for a number of national industry associations over a period of ten years in research, policy, public affairs and government relations roles, including Medicines Australia.

Sue has been a long-term carer for her son who has suffered from severe epilepsy since early adolescence.

Elisabeth de Somer

Elisabeth de Somer

Director of Policy and Advocacy, Medicines Australia

Read more

Elizabeth de Somer has had two careers in health, across England and Australia; Elizabeth’s first career was in nursing; working in intensive care as senior nurse, educator and researcher. Elizabeth’s second career has been with the pharmaceutical industry where she has held various roles in drug development, clinical research, manufacturing quality and drug safety, regulatory affairs, and broader medicines and vaccines health policy.

Elizabeth’s expertise lies in creating, implementing and evaluating effective health policy and the assessing the impact of government policy in the broader industry context, principally in prescription medicines; [although she has also worked in other areas of chemical regulation for security and law enforcement, as well as supply chain and emergency management policy].

Elizabeth has contributed her clinical and industry expertise to a number of expert committees providing advice to Government, including representing the industry on the sub-committees to the Pharmaceutical Benefits Advisory Committee (PBAC) [the Economic Sub-Committee ESC and Drug Utilisation Sub-Committees DUSC].

Elizabeth's academic qualifications lie in medical sciences and drug development, which lead her to provide occasional lectures on drug development, regulation of medicines, quality use of medicines and the policy environment affecting access to medicines in Australia.

Elizabeth is currently the Director of Policy and Advocacy at Medicines Australia, the peak body representing research based pharmaceutical companies in Australia, where she is responsible for leading collaboration with government and the development of sound policies to support access to prescription medicines for Australian patients.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Victor Loh

Victor Loh

Country Medical Director, Teva

Read more

Victor Loh is Country Medical Director for Teva Pharma Australia. In this role, he manages a team of Medical Managers and Medical Advisors. Being a start-up in Australia, the medical team in Teva is tasked with identifying gaps in the pipeline product data as well as in the local patient journeys. The team then conducts medical projects or studies to address these gaps to assist with regulatory and reimbursement submissions as well as to pave the way for a successful commercial launch of the products. Victor is also passionate about bringing more clinical trials to Australia and has been successful in increasing the number of trials in CNS and Respiratory in global Phase I to Phase III and regional Phase IV studies for Teva.

Victor graduated from the University of Sydney with a Bachelor of Medicine and Bachelor of Surgery and obtained his Master of Business Administration from the University of Melbourne through the Universitas 21 Global Graduate School program. He worked in clinical medicine in Malaysia for over five years before starting his pharmaceutical career with sanofi-aventis Malaysia. He then spent 6 years with Bayer in various roles across 3 countries, moving from Malaysia to Australia and to the regional office in Singapore as part of a talent development program at Bayer. Prior to his current role, Victor was Head of Medical for Solid and Rare Tumours during which, he led a team of Medical Advisors and Medical Science Liaisons.

Victor is a Fellow of the Australian Institute of Management and participates in the mentorship program for new managers in Australia.

Deborah Monk

Deborah Monk

Director Compliance, Medicines Australia

Read more

Deborah holds a Bachelor of Pharmacy from the University of Sydney and a Diploma in Hospital Pharmacy. She also holds a Bachelor of Arts from Macquarie University and recently completed the Masters in Public Policy degree at the University of Sydney

Deborah started her working life as a clinical pharmacist in the Pharmacy Department at a major teaching hospital in Sydney.

Deborah is currently the Director of Compliance at Medicines Australia.

Medicines Australia promotes the interests of the industry by encouraging a favourable investment environment, working on behalf of its members in an advocacy and consultative capacity with government and non-government organisations in Australia and overseas.

Deborah’s primary responsibility within Medicines Australia is to manage the Ethical Conduct Program.

Sandro Mancy

Sandro Mancy

Digital Marketing Specialist, Boehringer-Ingelheim

Read more

More information coming soon...

John Compton

John Compton

Training and Development Manager, Mylan EPD

Read more

John Compton is the Training & Development Manager at Mylan who partners with commercial teams to design, implement and improve internal capabilities.

His area of expertise is identifying performance needs, linking performance improvement to results, and using digital platforms to support this process.

John enjoys working on offering creative and customised solutions to help enable individuals, managers and teams reach the results they have planned for.

Julie-Anne Mitchell

Julie-Anne Mitchell

Director of Cardiovascular Health Programs, National Heart Foundation Australia NSW

Read more

Ms Julie Anne Mitchell is the NSW Director of Cardiovascular Health programs at the Heart Foundation where she has responsibility for the development and implementation of a range of cardiovascular health programs in NSW covering the areas of nutrition, physical activity, tobacco control and clinical issues.

She was National chair of the Heart Foundation’s women and heart disease program called “Go Red for Women” from 2008-12 and she continues as the Heart Foundation’s ‘national spokesperson’ on women and heart disease. Currently she is the Heart Foundation’s National Lead on Secondary Prevention of cardiovascular disease.

Julie Anne has experience in working in government and the non-government sector in both Victoria and NSW and has previously worked in the areas of tobacco control, public health nutrition and women’s health. A major focus of her work has been in the development and implementation of public health policy.

In 2013 she was recognised as a Finalist in the NSW Telstra Business Women’s Awards for her work in promoting heart health messages to Australian women.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Sam Develin

Sam Develin

Reimbursement Manager, Medicines Australia

Read more

More information coming soon...

Chris Stemple

Chris Stemple

Sales & Marketing Director, Biogen

Read more

Chris Stemple is the Commercial Director at Biogen, with oversight of Sales, Marketing, Market Access and Regulatory. He has been with Biogen for 2 years, in that time successfully launching Tecfidera and Plegridy in Multiple Sclerosis, doubling the size of the product portfolio while also developing the pipeline outside of the core MS business.

Prior to joining Biogen, Chris spent four years at AstraZeneca in a variety of marketing roles, and two years with Novartis in Business Development. Before that he was with Biogen in their Boston headquarters, working in Financial Planning. Chris’ early career was in consulting, working with Accenture and Bain & Co. He holds an MBA from the Tuck School at Dartmouth College, and a MSc and BSc (hons) from the University of Melbourne.

Theo Antonopoulos

Theo Antonopoulos

Head of Sales & Marketing, MedAdvisor International

Read more

More information coming soon...

Kathleen Traynor

Kathleen Traynor

Marketing Effectiveness and Process Manager, Roche Australia

Read more

Kathleen leads the design, development and implementation of plans, programs and processes to enhance the effectiveness of the Roche marketing team. Customer engagement through multichannel communications excellence is a key focus area.

Paul White

Paul White

National Sales Manager, Oncology, Novartis Pharmaceuticals Australia

Read more

10+ years of Sales Management in Pharma with; Procter & Gamble, iNova, GSK and Novartis.

Experience in successfully managing and leading projects across all aspects of sales force including sales force design and build, change management, development of first-line-managers and representatives along with marketing highly successful prescription products in secondary care.

Pre-order your event brochure

Full speaker list • Full conference agenda • Audience breakdown


Tim Nunan

Tim Nunan

Therapy Area Lead, Pfizer

Read more

More information coming soon...

Claire Edgerton

Claire Edgerton

Sales Lead, Pfizer

Read more

More information coming soon...

Adrian Bootes

Adrian Bootes

Assistant Secretary Prescription Medicines Authorisation Branch, Medicines Regulation Division, TGA

Read more

Adrian is Assistant Secretary, TGA in charge of Prescription Medicines Authorisation. Adrian comes to TGA after a career as a CEO, professional board member, and regional and international leader in clinical research and regulatory affairs for major pharma. In addition to ensuring continued delivery and improvements of current processes, Adrian is currently involved in planning and delivering the prescription medicines component of the recently announced government’s response to the Expert Review into Medicines and Medicines Devices led by Prof Lloyd Sansom.

Don’t miss out in 2017

Have Your Say: We would like to welcome you to share ideas, opportunities or questions you would like answers to. Email your thoughts to anza@eyeforpharma.com to be a part of this discussion.

If you are interested in attending please contact us on the below details.

Anza Asahara

Anza Asahara

Project Director
eyeforpharma

Phone: +44 207 422 4312

Email: anza@eyeforpharma.com

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown